NIRAMAI has developed Thermalytix, an AI-based breast cancer screening solution that utilizes thermal imaging technology to detect breast abnormalities without radiation or physical contact. This portable and automated system provides high accuracy in early-stage cancer detection, addressing the critical need for accessible and non-invasive screening methods for women of all ages.
Funding
$7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional breast cancer screening methods like mammography can be invasive, involve radiation exposure, and may not be suitable for women of all ages or breast densities, leading to lower screening uptake and delayed detection, especially in low and middle-income countries.
Solution
NIRAMAI Health Analytix offers Thermalytix, an AI-powered breast cancer screening solution that utilizes high-resolution thermal sensing and patented machine learning algorithms to detect breast abnormalities through temperature mapping. The non-invasive, radiation-free, and touch-free procedure ensures patient privacy and comfort while analyzing over 400,000 temperature points to generate a quantitative risk score. Thermalytix can be deployed in hospitals, diagnostic centers, and community health programs, providing an accessible and accurate screening method suitable for women of all ages and breast densities. AI algorithms are trained on large datasets of thermal images correlated with radiological imaging and histopathology reports, reducing subjectivity and human error while improving accuracy over time.
Target Audience
Primary customers include hospitals, diagnostic centers, healthcare providers, and organizations involved in women's health, particularly those focused on early breast cancer detection and preventive wellness services.
Features
- AI-powered analysis of thermal scans using patented machine learning and deep learning algorithms
- Non-invasive and radiation-free screening process with no physical contact
- High-resolution thermal sensing device that measures temperature distribution on the chest
- Cloud-hosted analytics solution for automated report generation
- Quantitative report showing a breast health score and assisting doctors in identifying abnormal breast lesions
- Suitable for large-scale public health programs and corporate wellness initiatives
- Compliant with ISO 13485, MDSAP, ISO 27001, EU GDPR, and US HIPAA requirements
- SMILE-100 System with US FDA clearance for adjunctive use in visualizing high thermal activity patterns